While there is no doubt some growth is already priced in, over the medium to long term, I suspect this stock can deliver.

On a basic human level, a guidance upgrade signals “things are better than we thought they were”, so upgrades are worth noticing.

Duratec (ASX: DUR) has been winning new contracts and is guiding shareholders to expect strong earnings growth.

Alcidion is an unprofitable healthcare software stock, and Duratec is a low margin contractor. But both companies are winning new contracts.

These 5 stocks each have strong share price momentum backed up by strong recent profit growth.